Division of Rheumatology, Department of Internal Medicine, University of Pisa, Via Roma, 67, 56100 Pisa, Italy.
Rheumatol Int. 2012 Feb;32(2):335-41. doi: 10.1007/s00296-010-1620-1. Epub 2010 Nov 18.
In our previous study, we observed that the presence of autoimmune thyroid disease worsens fibromyalgia (FM) symptoms. The aims of this study are to evaluate whether there is a predisposition for the development of FM in patients with Hashimoto's thyroiditis (HT) with or without subclinical hypothyroidism (SCH) and in patients with SCH alone and what is the weight of antithyroid antibody positivity and SCH on FM comorbidity. Fifty-two patients, 39 affected by HT with or without SCH and 13 by SCH, were matched with 37 patients affected by FM and 25 healthy subjects. Blood samples were collected from all study subjects for the determination of serum TSH, free triiodothyronine, free thyroxine, antithyroperoxidase antibody (TPOAb), antithyroglobulin antibody (TgAb) and non-organ-specific autoantibodies. Clinical assessment of patients and controls included the "Fibromyalgia Impact Questionnaire" (FIQ), while pain severity was evaluated using a visual analogue scale (VAS). Patients and controls were also characterized by the presence of diffuse pain, fatigue, paresthesiae, muscle spasms, non-restful sleep, tension headache and presence of mood disorders. FM comorbidity resulted in twelve HT subjects (31%) and none in SCH patient. In particular, FM comorbidity in HT patients without SCH was 33.3% and in HT patients with SCH was 28.5%. Based on our data, we speculate that maybe there is more than a hypothesis regarding the cause-effect relation between thyroid autoimmunity and the presence of FM, thus suggesting a hypothetical role of thyroid autoimmunity in FM pathogenesis.
在我们之前的研究中,我们观察到自身免疫性甲状腺疾病的存在会使纤维肌痛(FM)症状恶化。本研究的目的是评估桥本甲状腺炎(HT)患者伴或不伴亚临床甲状腺功能减退症(SCH)以及单独伴 SCH 的患者中是否存在 FM 发展的倾向,以及抗甲状腺抗体阳性和 SCH 对 FM 合并症的影响。52 名患者,39 名患有 HT 伴或不伴 SCH,13 名患有 SCH,与 37 名患有 FM 和 25 名健康受试者相匹配。从所有研究对象采集血样,以测定血清促甲状腺激素(TSH)、游离三碘甲状腺原氨酸、游离甲状腺素、甲状腺过氧化物酶抗体(TPOAb)、甲状腺球蛋白抗体(TgAb)和非器官特异性自身抗体。对患者和对照组进行临床评估,包括“纤维肌痛影响问卷”(FIQ),同时使用视觉模拟量表(VAS)评估疼痛严重程度。患者和对照组还表现为弥漫性疼痛、疲劳、感觉异常、肌肉痉挛、睡眠不安、紧张性头痛和情绪障碍。FM 合并症发生在 12 名 HT 患者(31%)中,而 SCH 患者中无一例发生。具体而言,HT 患者伴 SCH 时 FM 合并症发生率为 28.5%,而 HT 患者不伴 SCH 时 FM 合并症发生率为 33.3%。根据我们的数据,我们推测,甲状腺自身免疫与 FM 存在之间可能存在不仅仅是假设的因果关系,这提示了甲状腺自身免疫在 FM 发病机制中的假设作用。